HeartSciences amends equity plan to 1.25M shares, grants 70K restricted shares to CEO and RSUs to other officers

HeartSciences Inc.

Board approved Amendment No. 3 to 2023 Equity Incentive Plan, increasing authorized shares from 1M to 1.25M plus annual evergreen.
CEO Andrew Simpson granted 70,000 restricted shares; COO Mark Hilz 45,000 RSUs; CFO Danielle Watson 15,000 RSUs; each non-employee director 15,000 RSUs.
Equity awards vest over 2-3 years with continued service; accelerated vesting if Company reaches $250K+ revenue in any future fiscal quarter.
Amendment and grants conditioned on shareholder approval of Plan Amendment at next annual meeting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.